עברית

Prof. Alan Apter

Baruch Ivcher School of Psychology

  • Prof. Alan Apter MD, Director Of Feinberg Child Study Center, Schneider's Children's Medical Center of Israel and Professor of Psychiatry, Reichman University and Sackler School of Medicine, University of Tel Aviv. Former Chairman, Department of Psychiatry, Sackler School of Medicine University of Tel Aviv.
    He received his medical education from the University of Witwatersrand, Johannesburg in 1969 and his psychiatric qualifications in Israel and the US. He is a visiting professor at Yale, Pittsburgh and Columbia Universities in the USA and Foreign Adjunct Professor at the Karolinska Institute in Stockholm. Prof. After is a world-renowned researcher in the field of suicide. He is the winner of the University of Toronto's Farrington Award and Columbia University's Brickel Award. He was also awarded the American Foundation for Suicide Prevention Distinguished Investigator Award, as well as the Excellence Award by the World Health Organization's Suicide Prevention Center.

    Prof. Apter serves on the boards of several distinguished publications, including the Israel Journal of Psychiatry & Allied Sciences, the Journal of Neural Transmission, the Archives of Suicide Research (contributing editor), the European Journal of Child and Adolescent Psychiatry and the Journal of Child Psychiatry and Psychology.
    He serves on several state committees, including the Israel government's Interdepartmental Committee for Suicide Prevention of Adolescents, the Committee for Child Placement Laws at the Ministry of Social Affairs, the Health Ministry's Committee on the Licensing of Firearms for the Mentally Impaired, and the Defense Ministry's Suicide Prevention Committee. He also serves as a special advisor on suicide prevention to the Israel Defense Forces, and is an adviser for the National Centre for Suicide Research and Prevention of Mental Illness in Sweden.
    Prof. Apter has penned six book and more than 400 papers in international journals. He has led SCMCI site in three FP7 European-multicenter studies.